United Therapeutics Corp (UTHR)
234.36
+0.30
(+0.13%)
USD |
NASDAQ |
Apr 23, 16:00
234.42
+0.06
(+0.03%)
After-Hours: 20:00
United Therapeutics Gross Profit Margin (Quarterly): 88.45% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 88.45% |
| September 30, 2023 | 88.50% |
| June 30, 2023 | 89.25% |
| March 31, 2023 | 89.68% |
| December 31, 2022 | 88.04% |
| September 30, 2022 | 92.79% |
| June 30, 2022 | 93.64% |
| March 31, 2022 | 94.39% |
| December 31, 2021 | 91.67% |
| September 30, 2021 | 93.77% |
| June 30, 2021 | 91.67% |
| March 31, 2021 | 93.93% |
| December 31, 2020 | 90.96% |
| September 30, 2020 | 93.69% |
| June 30, 2020 | 92.85% |
| March 31, 2020 | 93.43% |
| December 31, 2019 | 90.74% |
| September 30, 2019 | 91.78% |
| June 30, 2019 | 92.85% |
| March 31, 2019 | 91.97% |
| December 31, 2018 | 91.64% |
| September 30, 2018 | 87.42% |
| June 30, 2018 | 86.12% |
| March 31, 2018 | 86.33% |
| December 31, 2017 | 88.59% |
| Date | Value |
|---|---|
| September 30, 2017 | 95.62% |
| June 30, 2017 | 95.75% |
| March 31, 2017 | 96.14% |
| December 31, 2016 | 93.06% |
| September 30, 2016 | 94.22% |
| June 30, 2016 | 95.15% |
| March 31, 2016 | 99.81% |
| December 31, 2015 | 93.75% |
| September 30, 2015 | 98.21% |
| June 30, 2015 | 95.39% |
| March 31, 2015 | 93.65% |
| December 31, 2014 | 95.44% |
| September 30, 2014 | 87.63% |
| June 30, 2014 | 88.01% |
| March 31, 2014 | 89.43% |
| December 31, 2013 | 86.58% |
| September 30, 2013 | 89.84% |
| June 30, 2013 | 88.48% |
| March 31, 2013 | 88.04% |
| December 31, 2012 | 84.55% |
| September 30, 2012 | 88.47% |
| June 30, 2012 | 86.86% |
| March 31, 2012 | 88.23% |
| December 31, 2011 | 87.02% |
| September 30, 2011 | 88.76% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
88.04%
Minimum
Dec 2022
94.39%
Maximum
Mar 2022
91.69%
Average
91.78%
Median
Sep 2019
Gross Profit Margin (Quarterly) Benchmarks
| Liquidia Corp | 78.08% |
| Esperion Therapeutics Inc | 64.49% |
| Vertex Pharmaceuticals Inc | 85.38% |
| Heron Therapeutics Inc | 71.12% |
| Aldeyra Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 18.22% |
| Return on Assets | 14.80% |
| Return on Invested Capital | 15.92% |
| Profit Margin (Quarterly) | 35.32% |
| Operating Margin (Quarterly) | 42.31% |
| Return on Net Operating Assets | 73.32% |